微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 12.71% | 1.38% | -2.87% | 141/159 | -2.82% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 13.09% | -6.19% | -0.24% | 145/159 | 15.28% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 13.12% | -16.62% | 7.67% | 142/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 12.19% | -6.17% | -2.82% | 146/159 | 51.78% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 12.54% | -14.01% | -10.12% | 145/159 | 22.81% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 13.95% | -3.88% | -11.33% | 145/159 | 33.25% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 15.73% | -18.38% | 21.16% | 140/159 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 12.99% | -44.32% | -10.94% | 144/159 | 51.39% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 14.58% | 2% | 0.46% | 142/159 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 14.52% | -45.73% | -24.71% | 141/159 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 19.28% | 2% | -17.34% | 135/159 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 23.32% | -30.66% | -12.79% | 136/159 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 26.74% | -22.32% | -20.49% | 128/159 | 21.37% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 33.64% | -12.51% | -2.31% | 121/159 | 55.1% | 迈威生物 | 99.44% | 行业排名> |
| 2021-06-30 | 34.43% | -13.32% | -10.44% | 113/159 | 47.23% | 迈威生物 | 98.57% | 行业排名> |
| 2020-12-31 | 38.44% | 4.03% | -3.21% | 110/159 | -145.9% | 首药控股 | 99.93% | 行业排名> |
| 2020-06-30 | 39.72% | 5.95% | 7.49% | 97/159 | 54.11% | 艾力斯 | 99.41% | 行业排名> |
| 2019-12-31 | 36.95% | 65.23% | -1.44% | 105/159 | -1222.98% | 艾力斯 | 98.7% | 行业排名> |
| 2019-06-30 | 37.49% | 2% | 67.64% | 85/159 | 55.21% | 艾力斯 | 99.4% | 行业排名> |
| 2018-12-31 | 22.36% | 2% | 2% | 127/159 | -208.09% | 首药控股 | 99.94% | 行业排名> |